Harbor granted China National Pharmaceutical Group's China State Institute of Pharmaceutical Industry (CIPI) subsidiary development and commercialization rights to HE2000, Apoptone and Triolex in China

Harbor BioSciences Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

China National Pharmaceutical Group Corp. (Sinopharm)

China / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced